Cargando…
Coexistence of anti-HMGCR and anti-MDA5 identified by an unlabeled immunoprecipitation assay in a chinese patient cohort with myositis
Myositis-specific autoantibodies are important diagnostic and prognostic markers. The aim of our study is to detect anti-3-hydroxy 3-methylutaryl coenzyme A reductase (anti-HMGCR) antibody using novel unlabeled immunoprecipitation (IP) assay and immunoblotting in Chinese patients with myositis and t...
Autores principales: | Huang, Li, Wang, Li, Yang, Yang, Chen, Huan, Liu, Yanjuan, Liu, Ke, Liu, Meidong, Xiao, Yizhi, Zuo, Xiaoxia, Li, Yisha, Luo, Hui, Zhang, Huali, Xiao, Xianzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392932/ https://www.ncbi.nlm.nih.gov/pubmed/30461626 http://dx.doi.org/10.1097/MD.0000000000013236 |
Ejemplares similares
-
Clinical Features and Cytokine Profile in Myositis Patients with Anti-EJ Autoantibodies Detected by a Novel Immunoprecipitation Assay
por: Yang, Yang, et al.
Publicado: (2019) -
Increased Serum Matrix Metalloproteinase-9 Levels are Associated with Anti-Jo1 but not Anti-MDA5 in Myositis Patients
por: Liu, Yanjuan, et al.
Publicado: (2019) -
Anti-HMGCR Myopathy
por: Mohassel, Payam, et al.
Publicado: (2018) -
Anti-HMGCR antibodies in systemic sclerosis
por: Hudson, Marie, et al.
Publicado: (2016) -
Screening for Anti-HMGCR Antibodies in a Large Single Myositis Center Reveals Infrequent Exposure to Statins and Diversiform Presentation of the Disease
por: Szczesny, Piotr, et al.
Publicado: (2022)